Loading stock data…
BIOX
$0.47+0.00 (+0.21%)
Market ClosedLast close May 1
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bioceres Crop Solutions Corp. in the Basic Materials sector is trading at $0.47. The stock is currently near its 52-week low of $0.35, remaining 69.6% below its 200-day moving average. Technical signals show neutral RSI of 39 and bearish MACD signal, explaining why BIOX maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 39) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.47
Potential Upside
5%
Whystock Fair Value$0.49
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products s...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$40.73M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-324.73%
Volume
Today's trading volume
104,595
Recent News
What Recent Funding Pressures Mean For Bioceres Crop Solutions Valuation Narrative
Bioceres Crop Solutions stock has seen its price target framework subtly recalibrated as analysts balance the company’s differentiated agricultural technology portfolio against rising macro and funding risks in Argentina. While the core revenue growth outlook remains intact near 8.2%, a slightly higher discount rate signals a more cautious stance on country and execution risk. This leaves fair value per share broadly steady around $2.25. Read on to see how this evolving narrative may continue...
Why Analysts Say Bioceres’ Story Is Shifting Amid Liquidity Fears Yet Long Term Promise
Bioceres Crop Solutions has just seen its fair value estimate cut from $3.63 to $2.25 per share, even as analysts nudge their revenue growth outlook slightly higher and trim the discount rate applied to the stock. This recalibration reflects a market narrative that is growing more cautious on near term liquidity and execution risk in Argentina, yet still credits the company with solid long term earnings potential from its next generation product pipeline. Stay tuned to learn how you can track...
How Recent Developments Are Rewriting the Story for Bioceres Crop Solutions
Bioceres Crop Solutions stock has come under fresh scrutiny as analysts adjust their outlook. The consensus analyst price target has dipped slightly from $3.75 to $3.63, reflecting a reassessment of both opportunities and risks facing the company. Stay tuned to discover how you can stay ahead of further narrative shifts as analysts continue to evaluate Bioceres’ prospects. Stay updated as the Fair Value for Bioceres Crop Solutions shifts by adding it to your watchlist or portfolio...
Bioceres Crop Solutions Corp (BIOX) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
Despite a 17% drop in revenues, Bioceres Crop Solutions Corp (BIOX) achieved a 61% increase in adjusted EBITDA through effective cost reduction and business model transition.
Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates
Bioceres Crop (BIOX) delivered earnings and revenue surprises of -200.00% and -18.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?